China and the US have put aside some of their differences temporarily to work together to develop early warning systems that warn individuals who are vulnerable to the new coronavirus (Covid-19). The virus started late last year in Wuhan China and has quickly spread across the globe. At the time of this writing the virus has killed more than 50,000 around the world.
AI Vulnerability Testing Kits Reportedly 80% Accurate
Researchers from Wenzhou Central Hospital, New York University, and Cangnan People’s Hospital are developing Artificial Intelligence (AI)-based early warning systems, which will later predict whether a patient will show an acute symptom of Covid-19 or not, especially in the elderly, as South China Morning Post reported.
The system will rely on data from those three institutions. From there, the AI system they are using will measure several factors including the amount of liquid in humans’ lungs, muscle problems, and so on. The analysis will predict with a high degree of accuracy who is most vulnerable to life-threatening symptoms from Covid-19.
The system has been tested on 53 patients so far in Wenzhou, China. The result is reportedly quite satisfactory, with researchers claiming the system’s accuracy has reached 80 percent.
Using AI in Medicine
AI refers to the simulation of human intelligence in a machine programmed to think like a human and copy his or her acts and pursue logical decision-making processes.The application of AI in the medical field is not new. One of the most common uses of AI in medicine is the management of medical records, handled by a machine. The application works by collecting, storing, and tracing data, aimed at providing faster and more consistent access.
AI technology has also developed a machine that can monitor a patient’s condition called Molly. The virtual nurse is used to follow up the treatment and provide caring for a patients suffering from chronic disease.
AI-Based Test Kits Don’t Need to Draw Blood
Indonesian AI practitioner, Karim Taslim, stated that the latest AI-based test, which requires no blood or genetic material, and swab tests had been applied in Wuhan with a 90 percent accuracy rate.
The expert told Tempo that the new AI-based device can be potentially deployed in Indonesia as it is connected to CT scan machines available in all Indonesia’s government hospitals. The device can read the test only in ten seconds.
Shanghai Research Center for Brain Science and Brain-inspired Intelligence in collaboration with China Academic of Sciences, Neurobionix, and Skymind Laboratory of Neurobionix Research have produced this test kit under the name Axial AI (uAI Discover PNA).
Axial AI can also monitor the health condition’s progress of Covid-19 patients it can compare the stored CT scan image with the latest one from time to time, ensuring that patients will receive early and consistent treatment.
Don’t Dismiss the Human Factor
As researchers are racing to produce the best vaccines to contain the virus, the use of AI sounds promising. However, humans still play a vital element in operating technology.
First, the use of AI must not infringe patients’ privacy rights. Several European countries such as the U.K, Belgium, and Italy have collected anonymized data to study people’s mobility in a general manner, ensuring that the risk of a data breach is minimized.
Second, the correct data input is essential. Humans can detect places where algorithms fail and situations where historical data is still relevant to tackle real-time issues while waiting for the most current data to be provided.